MariMed stockholders re-elect four directors and approve auditors at 2026 annual meeting

MARIMED INC.

Re-elected directors Levine, Gildea, Allen, and Selhub; each received over 110M votes for.
Advisory approval of M&K CPAs PLLC as FY2026 auditors: 229.3M for, 15.6M against, 0.6M abstain.
Broker non-votes of 119.8M shares on director elections due to discretionary voting rules.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

MARIMED INC. shareholders approved Advisory approval of the appointment of M&K CPAs PLLC as the Company's independent auditors for fiscal year 2026. at the 2026-06-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

VOTES FOR AGAINST ABSTAIN/WITHHELD 229,335,138 15,550,371 574,116

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

MARIMED INC. shareholders approved Election of four directors to serve until the next annual meeting or until successors are elected and qualified. at the 2026-06-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-04

Exact text from the filing

VOTES NAME FOR WITHHELD BROKER NON-VOTE Jon R. Levine 111,339,122 14,355,396 119,765,107 Edward Gildea 110,868,950 14,825,568 119,765,107 David Allen 110,854,282 14,840,236 119,765,107 Eva Selhub, M.D. 111,358,888 14,335,630 119,765,107

View on SEC.gov

Browse all shareholder votes →

MARIMED INC. filing history →

Source: SEC EDGAR

accession 0001522767-26-000107

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.